Original Research
Accepted on 28 Nov 2025
Characteristics of adverse events and clinical risks of Intravenous immunoglobulin: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)
in Regulatory Science
- 354 views
Original Research
Accepted on 28 Nov 2025
in Regulatory Science
Original Research
Accepted on 28 Nov 2025
in Regulatory Science
Original Research
Published on 26 Nov 2025
in Regulatory Science
Systematic Review
Accepted on 24 Nov 2025
in Regulatory Science
Review
Published on 24 Nov 2025
in Regulatory Science
Original Research
Published on 21 Nov 2025
in Regulatory Science
Policy and Practice Reviews
Published on 20 Nov 2025
in Regulatory Science
Review
Published on 19 Nov 2025
in Regulatory Science
Original Research
Accepted on 17 Nov 2025
in Regulatory Science
Original Research
Accepted on 17 Nov 2025
in Regulatory Science
Original Research
Accepted on 13 Nov 2025
in Regulatory Science
Review
Accepted on 13 Nov 2025
in Regulatory Science
Hypothesis and Theory
Accepted on 11 Nov 2025
in Regulatory Science
Systematic Review
Published on 11 Nov 2025
in Regulatory Science
Original Research
Published on 11 Nov 2025
in Regulatory Science
Original Research
Published on 11 Nov 2025
in Regulatory Science